Epigenomics AG Profile Avatar - Palmy Investing

Epigenomics AG

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The co…
Medical - Diagnostics & Research
DE, Berlin [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million EUR. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
16.00 33.00 19.00 6.00 11.00 11.00 12.00 18.00 19.00 21.00 13.00 6.00 24.00 15.00 12.00
Current
10.00 28.00 15.00 3.00 8.00 8.00 10.00 15.00 16.00 18.00 12.00 5.00 23.00 10.00 2.00
Non Current
5.00 5.00 4.00 3.00 2.00 2.00 1.00 3.00 2.00 3.00 1.00 1.00 - - 5.00 10.00
Liabilities
4.00 2.00 3.00 2.00 4.00 5.00 5.00 3.00 9.00 3.00 4.00 2.00 2.00 5.00 20.00
Current
4.00 2.00 3.00 2.00 4.00 3.00 5.00 3.00 9.00 3.00 3.00 2.00 2.00 5.00 - -
Non Current
- - - - - - - - - - 1.00 - - - - - - - - - - - - - - - - 20.00
Equity
12.00 31.00 16.00 4.00 6.00 6.00 7.00 14.00 10.00 18.00 9.00 3.00 22.00 10.00 -8.00
Stockholders' Equity
12.00 31.00 16.00 4.00 6.00 6.00 7.00 14.00 10.00 18.00 9.00 3.00 22.00 10.00 -8.00
Retained Earnings
-22.00 -33.00 -14.00 -26.00 -33.00 -42.00 -51.00 -62.00 -73.00 -85.00 -102.00 -90.00 -93.00 -96.00 -85.00
Common Stock
29.00 44.00 8.00 8.00 13.00 15.00 18.00 22.00 24.00 36.00 43.00 5.00 15.00 4.00 - -
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Profit
-10.00 -11.00 -15.00 -12.00 -7.00 -8.00 -8.00 -11.00 -10.00 -12.00 -17.00 -11.00 -2.00 -12.00 -4.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
5.00 21.00 21.00 21.00 27.00 33.00 40.00 54.00 59.00 68.00 68.00 87.00 99.00 102.00 - -
Loss Other Compr. Income
- - - - - - - - - - - - - - - - - - - - - - 1.00 - - - - 76.00
End of EPGNF's Analysis
CIK: - CUSIP: - ISIN: DE000A37FT41 LEI: - UEI: -
Secondary Listings
EPGNF has no secondary listings inside our databases.